Provided by Tiger Fintech (Singapore) Pte. Ltd.

Globus Medical

59.17
-1.4000-2.31%
Post-market: 59.170.00000.00%16:20 EDT
Volume:1.81M
Turnover:107.37M
Market Cap:8.01B
PE:44.29
High:60.82
Open:60.30
Low:58.81
Close:60.57
Loading ...

BTIG Sticks to Their Buy Rating for Globus Medical (GMED)

TIPRANKS
·
13 Jan

GMED Stock Rides on NuVasive Synergy Benefits Amid Macro Issues

Zacks
·
10 Jan

Globus Medical (GMED) Gets a Buy from Piper Sandler

TIPRANKS
·
10 Jan

Globus Medical price target raised to $101 from $92 at Canaccord

TIPRANKS
·
10 Jan

Globus Medical, Inc.'s (NYSE:GMED) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Simply Wall St.
·
10 Jan

U.S. RESEARCH ROUNDUP-Antero Resources, IGM Biosciences, Lennar

Reuters
·
10 Jan

Globus Medical Inc : Canaccord Genuity Raises Target Price to $101 From $92

THOMSON REUTERS
·
10 Jan

Analysts Offer Insights on Healthcare Companies: Globus Medical (GMED) and Reviva Pharmaceuticals Holdings (RVPH)

TIPRANKS
·
10 Jan

Globus Medical Inc : Jefferies Raises Target Price to $105 From $100

THOMSON REUTERS
·
10 Jan

Globus Medical Raised to Neutral From Underperform by B of A Securities

Dow Jones
·
09 Jan

Globus Medical Inc : Bofa Global Research Raises Price Objective to $97 From $80

THOMSON REUTERS
·
09 Jan

Globus Medical upgraded to Neutral from Underperform at BofA

TIPRANKS
·
09 Jan

Needham Keeps Their Hold Rating on Globus Medical (GMED)

TIPRANKS
·
09 Jan

Positive Outlook and Buy Rating for Globus Medical Amid Strong Sales and Market Confidence

TIPRANKS
·
09 Jan

BTIG Sticks to Their Buy Rating for Globus Medical (GMED)

TIPRANKS
·
09 Jan

Globus Medical Reports Preliminary Q4 Sales, Sets 2025 Guidance

MT Newswires Live
·
09 Jan

Globus Medical sees Q4 revenue $657M, consensus $635.46M

TIPRANKS
·
09 Jan

Globus Medical raises FY24 revenue view to $2.52B from $2.49B-$2.5B

TIPRANKS
·
09 Jan

Globus Medical sees FY25 EPS $3.40-$3.50, consensus $3.42

TIPRANKS
·
09 Jan

Globus Medical Reports Preliminary Q4 Sales $657M, Up 6.6% YoY; FY24 Sales $2.52B, Up 60.6% YoY; Sees 2025 Revenue $2.66B-$2.69B Vs $2.67B Est.; Non-GAAP EPS $3.40-$3.50 Vs $3.42 Est.

Benzinga
·
09 Jan